Ann: Cynata Investor Presentation, page-12

Clearly even the first 2 have clear metrics that others can't seem to see through foggy lenses.

1. START NEW CLINICAL TRIALS
2. RECRUITMENT for MEND
3. OA trail, no brainer, already on the way

probably just the last one has been on repeat for a long time, and not new or specific.

then there's the wait for FUJI to get cracking, mostly not in CYPs control.

9.5 months to go, and agree, if not achieved by end 2021 after last 2 years, I reckon Ross should face a mutiny, even by own board.

There is absolutely plenty of opportunities on the table right now, more than ever before by far.
DFU looks next new one off the blocks